Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.54 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.54 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.54 |
| ▸ | RUNX1 | Q01196 | 1/20 | 0.54 |
| ▸ | CBFB | Q13951 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LDHA | P00338 | 2/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8863163 | 0.87 | LDHA (0.57) | KDM4EMEN1NPC1RAB9AKMT2A | |
| SCHEMBL22341666 | 0.85 | HSD11B1 (0.63) | HSD11B1KDM4EMEN1NPC1RAB9A | |
| SCHEMBL13076421 | 0.84 | HSD11B1 (0.55) | HSD11B1AURKAHIF1AALDH1A1KEAP1 | |
| SCHEMBL6653400 | 0.83 | HSD11B1 (0.58) | HSD11B1MEN1NPC1RAB9AKMT2A | |
| SCHEMBL9508191 | 0.83 | HSD11B1 (0.58) | HSD11B1MAPTAURKAHIF1AALDH1A1 | |
| SCHEMBL11770138 | 0.80 | HSD11B1 (0.58) | HSD11B1MEN1NPC1RAB9AKMT2A | |
| SCHEMBL18180168 | 0.80 | HSD11B1 (0.54) | HSD11B1MEN1NPC1RAB9AKMT2A | |
| SCHEMBL8861663 | 0.78 | NPC1 (0.53) | HSD11B1KDM4EMEN1NPC1RAB9A | |
| SCHEMBL5803760 | 0.78 | HSD11B1 (0.65) | HSD11B1MEN1NPC1RAB9AKMT2A | |
| SCHEMBL13006762 | 0.78 | ALDH1A1 (0.50) | HSD11B1AURKAHIF1AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2429993-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INT (DE) | 2015-01-21 | — | — | EP | disclosed |
| US-8841331-B2 | Inhibitors of human immunodeficiency virus replication | GILEAD SCIENCES, INC. (US) | 2014-09-23 | — | — | US | disclosed |
| US-8338441-B2 | Inhibitors of human immunodeficiency virus replication | GILEAD SCIENCES, INC. (US) | 2012-12-25 | — | — | US | disclosed |
| US-8338441-B2 | Inhibitors of human immunodeficiency virus replication | GILEAD SCIENCES, INC. (US) | 2012-12-25 | — | — | US | disclosed |
| EP-1465882-B1 | HETROCYCLIC MODULATORS OF NUCLEAR RECEPTORS | X CEPTOR THERAPEUTICS INC (US) | 2011-08-24 | — | — | EP | disclosed |
| WO-2010130034-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | WO | disclosed |
| US-20100292227-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | US | disclosed |
| US-20100292227-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | US | disclosed |
| EP-1211555-B1 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJIFILM CORP (JP) | 2008-12-31 | — | — | EP | disclosed |
| US-7115640-B2 | Heterocyclic modulators of nuclear receptors | X-CEPTOR THERAPEUTICS, INC. (US) | 2006-10-03 | — | — | US | disclosed |
| EP-0367243-A1 | A silver halide photographic light-sensitive material excellent in antistatic property | KONICA CORPORATION (JP) | 1990-05-09 | — | — | EP | disclosed |
| US-4917997-A | MIXED WITH ASCORBIC ACID COMPONENT, SENSITIZING DYE, BISAMINOSTILBENE WITH PYRIMIDINE SUBSTITUTION | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-17 | — | — | US | disclosed |
| EP-0357082-A2 | Silver halide photographic emulsions | FUJI PHOTO FILM CO., LTD. (JP) | 1990-03-07 | — | — | EP | disclosed |
| US-4308345-A | CYANINE DYES FOR COLOR | FUJI PHOTO FILM CO., LTD. (JP) | 1981-12-29 | — | — | US | disclosed |
| US-4307185-A | SENSITIZING DYE OF CYANINE STRUCTURE | FUJI PHOTO FILM CO., LTD. (JP) | 1981-12-22 | — | — | US | disclosed |
| US-4212672-A | CYANINE SENSITIZER DYE, SULFONIC ACID-SUBSTITUTED HETEROCYCLIC COMPOUND, POLYOXYALKYLENE OXIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1980-07-15 | — | — | US | disclosed |
| US-4121935-A | CARBOCYANINE DYES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1978-10-24 | — | — | US | disclosed |
| US-4047964-A | BENZISOXAZOLE | FUJI PHOTO FILM CO., LTD. (JA) | 1977-09-13 | — | — | US | disclosed |
| US-4040841-A | SENSITIZING DYE | FUJI PHOTO FILM CO., LTD. (JA) | 1977-08-09 | — | — | US | disclosed |
| US-4018610-A | Supersensitized silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. (JA) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292227-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | RTF2, REV1, RTF1 | HSD11B1 2249/4885KDM4E 1453/4885MEN1 3840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.